Sintilimab, CAS 2072873-06-2

Product Description: Sintilimab (IBI308) is a fully human IgG4 monoclonal antibody that binds to PD-1, thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2) and consequently helping to restore the endogenous antitumour T-cell response. Sintilimab can be used for the research of classical Hodgkin's lymphoma, non-small cell lung cancer and oesophageal cancer[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Sheridan M Hoy. Sintilimab: First Global Approval Drugs. 2019 Feb;79(3):341-346.

CAS Number: 2072873-06-2

Molecular Weight: N/A

Compound Purity: 98.70

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: PD-1/PD-L1

• SKU: MEXHY-P99048-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99048-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK